High Court lets stand Pfizer’s early discovery win
Ashurst 2018-06-04 10:55 pm By Christine Caulfield | Melbourne
Please login to bookmark Close

The High Court has rejected a bid by biopharmaceutical company Samsung Bioepis Australia to challenge a ruling granting Pfizer preliminary discovery for a potential patent infringement case over autoimmune drug Enbrel.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?

For information on rights and reprints, contact subscriptions@lawyerly.com.au